AJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Uysal, E.
Right arrow Articles by Basak, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Uysal, E.
Right arrow Articles by Basak, M.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Sensitivity of Immediate and Delayed Gadolinium-Enhanced MRI After Injection of 0.5 M and 1.0 M Gadolinium Chelates for Detecting Multiple Sclerosis Lesions

Ender Uysal1, Sukru Mehmet Erturk1, Hakan Yildirim1, Feray Seleker2 and Muzaffer Basak1

1 Department of Radiology, Sisli Etfal Hospital, Etfal Sok, Istanbul 80220, Turkey.
2 Department of Neurology, Sisli Etfal Hospital, Istanbul 80220, Turkey.


Figure 1
View larger version (174K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 1A —35-year-old man with multiple sclerosis. Axial fast spin-echo T2-weighted image (TR/TE, 4,800/102; inversion time, 2 milliseconds) shows plaque lesion at left side of pons near tectum.

 

Figure 2
View larger version (168K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 1B —35-year-old man with multiple sclerosis. Ten minutes after IV administration of 0.5-mol/L contrast medium (0.1 mmol/kg), no contrast enhancement attributable to this lesion is detectable on magnetization transfer contrast-enhanced T1-weighted image (560/15; inversion time, 1 millisecond).

 

Figure 3
View larger version (160K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 1C —35-year-old man with multiple sclerosis. Immediately after administration of 1.0-mol/L contrast medium (0.2 mmol/kg), focal contrast enhancement (arrowhead) is barely detectable.

 

Figure 4
View larger version (164K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 1D —35-year-old man with multiple sclerosis. However, 5 (D) and 10 (E) minutes after administration of 1.0-mol/L contrast medium (0.2 mmol/kg), enhancement is clearly visible in this lesion.

 

Figure 5
View larger version (164K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 1E —35-year-old man with multiple sclerosis. However, 5 (D) and 10 (E) minutes after administration of 1.0-mol/L contrast medium (0.2 mmol/kg), enhancement is clearly visible in this lesion.

 

Figure 6
View larger version (160K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 2A —27-year-old woman with multiple sclerosis (MS). Millimetric MS plaque lesions are seen in subcortical white matter and at periventricular region on axial fast spin-echo T2-weighted image.

 

Figure 7
View larger version (162K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 2B —27-year-old woman with multiple sclerosis (MS). Ten minutes after IV administration of 0.5-mol/L contrast medium (0.1 mmol/kg), no contrast enhancement attributable to a white matter lesion is detectable on magnetization transfer contrast-enhanced T1-weighted image.

 

Figure 8
View larger version (166K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 2C —27-year-old woman with multiple sclerosis (MS). Immediately after administration of 1.0-mol/L contrast medium (0.2 mmol/kg), there is also no contrast enhancement.

 

Figure 9
View larger version (171K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 2D —27-year-old woman with multiple sclerosis (MS). However, 5 (D) and 10 (E) minutes after administration of 1.0-mol/L contrast medium (0.2 mmol/kg), one enhancing lesion (arrowhead) is detectable in frontal left lobe. Note that enhancement is more prominent on latest image.

 

Figure 10
View larger version (168K):
[in this window]
[in a new window]
[as a PowerPoint slide]
  		Fig. 2E —27-year-old woman with multiple sclerosis (MS). However, 5 (D) and 10 (E) minutes after administration of 1.0-mol/L contrast medium (0.2 mmol/kg), one enhancing lesion (arrowhead) is detectable in frontal left lobe. Note that enhancement is more prominent on latest image.

 

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?



HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Roentgen Ray Society.